JY
SBIO icon

Jeff Yass’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Jeff Yass’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,686
Closed -$3.18M – 14382
2026
Q1 		$3.18M Buy
+60,686
New +$3.09M ﹤0.01% 5161
2025
Q4 		– Sell
-7,886
Closed -$306K – 13459
2025
Q3 		$306K Sell
7,886
-18,238
-70% -$627K ﹤0.01% 10060
2025
Q2 		$786K Buy
+26,124
New +$747K ﹤0.01% 8062
2025
Q1 		– Sell
-17,115
Closed -$565K – 13332
2024
Q4 		$565K Buy
17,115
+10,286
+151% +$388K ﹤0.01% 8370
2024
Q3 		$255K Sell
6,829
-13,608
-67% -$496K ﹤0.01% 9961
2024
Q2 		$686K Buy
20,437
+457
+2% +$15.3K ﹤0.01% 7476
2024
Q1 		$714K Buy
+19,980
New +$692K ﹤0.01% 7659
2023
Q4 		– Sell
-18,574
Closed -$499K – 13187
2023
Q3 		$506K Buy
18,574
+4,811
+35% +$145K ﹤0.01% 8196
2023
Q2 		$434K Sell
13,763
-7,097
-34% -$220K ﹤0.01% 8640
2023
Q1 		$567K Sell
20,860
-2,919
-12% -$88.1K ﹤0.01% 8260
2022
Q4 		$722K Sell
23,779
-31,906
-57% -$960K ﹤0.01% 6945
2022
Q3 		$1.68M Buy
55,685
+48,160
+640% +$1.52M ﹤0.01% 5312
2022
Q2 		$208K Buy
7,525
+204
+3% +$5.82K ﹤0.01% 10540
2022
Q1 		$246K Sell
7,321
-13,434
-65% -$466K ﹤0.01% 10750
2021
Q4 		$877K Buy
20,755
+11,707
+129% +$522K ﹤0.01% 7635
2021
Q3 		$412K Sell
9,048
-18,973
-68% -$871K ﹤0.01% 9859
2021
Q2 		$1.37M Buy
28,021
+2,970
+12% +$142K ﹤0.01% 6895
2021
Q1 		$1.26M Buy
25,051
+6,958
+38% +$385K ﹤0.01% 7112
2020
Q4 		$927K Buy
18,093
+1,272
+8% +$60.5K ﹤0.01% 6893
2020
Q3 		$691K Buy
16,821
+2,129
+14% +$87.8K ﹤0.01% 6987
2020
Q2 		$615K Sell
14,692
-80,351
-85% -$3.17M ﹤0.01% 6930
2020
Q1 		$3.01M Buy
+95,043
New +$3.64M ﹤0.01% 3276
2019
Q4 		– Sell
-25,691
Closed -$953K – 10506
2019
Q3 		$810K Buy
+25,691
New +$903K ﹤0.01% 6164
2019
Q1 		– Sell
-73,513
Closed -$2.46M – 9717
2018
Q4 		$2.07M Buy
73,513
+50,963
+226% +$1.69M ﹤0.01% 3474
2018
Q3 		$888K Buy
22,550
+10,884
+93% +$413K ﹤0.01% 5458
2018
Q2 		$435K Buy
+11,666
New +$423K ﹤0.01% 7079
2017
Q3 		– Sell
-22,343
Closed -$656K – 9525
2017
Q2 		$622K Buy
22,343
+4,402
+25% +$114K ﹤0.01% 6229
2017
Q1 		$462K Sell
17,941
-43,406
-71% -$1.08M ﹤0.01% 6624
2016
Q4 		$1.41M Buy
+61,347
New +$1.47M ﹤0.01% 4806
2016
Q2 		– Sell
-49,802
Closed -$1.18M – 9225
2016
Q1 		$1.09M Sell
49,802
-4,207
-8% -$96.2K ﹤0.01% 4909
2015
Q4 		$1.72M Buy
54,009
+4,211
+8% +$129K ﹤0.01% 4352
2015
Q3 		$1.39M Buy
49,798
+31,458
+172% +$1.1M ﹤0.01% 5033
2015
Q2 		$652K Buy
+18,340
New +$599K ﹤0.01% 7099

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jeff Yass's SBIO Position: Q2 2026 in Review

Jeff Yass sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 60,686 shares — an estimated $3.18M sold.

Jeff Yass first reported a position in SBIO in Q2 2015 and held it in 33 quarters. The position peaked at $3.18M in Q1 2026. 64 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Jeff Yass reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 60,686 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $3.18M.
  • Jeff Yass first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and held it in 33 quarters.
  • Jeff Yass's ALPS Medical Breakthroughs ETF position peaked at $3.18M in Q1 2026.
  • 64 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.